ASH 2017: Frontline Options
Drs. Brian G.M. Durie, Joseph Mikhael, and Paul Richardson discuss frontline treatment options for multiple myeloma patients, during the IMWG Conference Series filmed at 2017 American Society of Hematology (ASH) annual conference in Atlanta, Georgia.
We thank our supporters of this program:
Abbvie, AMGEN, Bristol-Myers Squibb Celgene Corporation, Janssen Oncology, Takeda Oncology
Previous Post
Best of ASH 2017
Next Post
ASH 2017: Role of Autologous Stem Cell Transplant (ASCT)